CG Oncology (CGON) EBT Margin (2023 - 2026)
CG Oncology (CGON) posted EBT Margin of 40904.25% for Q1 2026, down 2190.82% on a QoQ basis from 1785.57% in Q4 2025, and up 19326498.0% year-over-year from N/an in Q1 2025.
CG Oncology (CGON) EBT Margin (2023 - 2026) Analysis & Trends
CG Oncology's EBT Margin history runs 4 years deep, the most recent figure standing at 40904.25% for Q1 2026.
- Quarterly EBT Margin rose 19326498.0% year-over-year to 40904.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17098.46% (up 5890803.0% YoY) and the FY2025 annual result came in at 8895.74%, up 832963.0% from the prior year.
- EBT Margin was 40904.25% for Q1 2026 at CG Oncology, down from 1785.57% in the prior quarter.
- Across five years, EBT Margin topped out at 1785.57% in Q4 2025 and bottomed at 1655100.0% in Q4 2023.
- A 4-year average of 245795.72% and a median of 46903.4% in 2024 frame the typical range for EBT Margin.
- Peak annual rise in EBT Margin reached 164811228 bps in 2024, while the deepest fall reached 28167080 bps in 2024.
- CG Oncology's EBT Margin stood at 1655100.0% in 2023, then soared by 100 bps to 6987.72% in 2024, then soared by 74 bps to 1785.57% in 2025, then slumped by 2191 bps to 40904.25% in 2026.
- Business Quant data shows CGON's EBT Margin at 40904.25% in Q1 2026, 1785.57% in Q4 2025, and 14071.67% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | -40,904.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40,904.25% |
| Dec 31, 2025 | -1,785.57% |
| Sep 30, 2025 | -14,071.67% |
| Mar 31, 2025 | -234,169.23% |
| Dec 31, 2024 | -6,987.72% |
| Sep 30, 2024 | -412,993.02% |
| Jun 30, 2024 | -154,904.50% |
| Mar 31, 2024 | -46,903.40% |
| Dec 31, 2023 | -1,655,100.00% |
| Sep 30, 2023 | -131,322.22% |
| Mar 31, 2023 | -4,611.34% |